The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institutes Department of Science Education and the Robert Wood Johnson Foundation
The strategy of GLP-1RAs combined with non-pharmacological therapy for improving sarcopenia Given that the weight loss effect induced by GLP-1RAs is often accompanied by the risk of muscle loss, and this influence is regulated by multiple factors such as age, underlying diseases, and the duration of treatment, in order to retain muscle mass to the greatest extent, the clinical consensus suggests that GLP-1RA treatment must be combined with active non-pharmacological intervention
For instance, it is capable of inactivating GIP and GLP-1 peptides
doi: 10.1152/ajpregu.00153.2008 111 NakataniYKawabeAMatsumuraMAsoYYasuTBanbaNet al
Their lab markers such as insulin, CRP, triglycerides, told a story of rising inflammation
doi: Luz, Y., Calvi, I.P., Marques, I.R., Cruz, S.A., Messias, E., Emanuel, P., Azevedo, H., Cardoso, R., Moura, F.A